At Adiso, we create medicines to treat inflammatory diseases, improving the lives of patients and their families. Current treatment paradigms are far too often either inadequate to halt disease progression or burden the patient with significant safety concerns.
To tackle these challenges, we are advancing an innovative pipeline of small molecules (ADS051 & ADS032) and single strain live biotherapeutic products (SS-LBP :: ADS024) both with novel mechanisms of action.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Concord, Massachusetts 01742, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://adisotx.com
- Keywords
- Manager jobs.
- HQ
- Concord, Massachusetts
Adiso Therapeutics Questions
Adiso Therapeutics's website is http://adisotx.com
Adiso Therapeutics's LinkedIn profile is https://www.linkedin.com/company/adisotx
Adiso Therapeutics has
12 employees.
View email and phone details for 12
employees at Adiso Therapeutics.
Adiso Therapeutics's industry is
Biotechnology Research
Adiso Therapeutics's top competitors are
Mineralys Therapeutics, Inc.,
Incarda Therapeutics,
Alnylam Pharmaceuticals,
Agios Pharmaceuticals,
Acelyrin, Inc.,
Structure Therapeutics,
Beam Therapeutics,
Clearb Therapeutics,
Apogee Therapeutics,
Cadrenal Therapeutics, Inc. (Nasdaq: Cvkd).
Adiso Therapeutics's categories are Biotechnology Research
Adiso Therapeutics's founding year is 2022
